BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 12609063)

  • 1. [Construction, bioactivity identification and structural characteristics analysis of a novel recombinant immunosuppression protein B7-2-L-PE40KDEL].
    Yuan Z; Xi Y; Zhang H; Kong F; Guan H; Guo S; Liu N; Liang F; Sun Y; Cui J
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1541-5. PubMed ID: 12609063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of purification procedure for recombinant fusion protein B7-2-PE40KDEL].
    Guan HR; Sun YY; Yuan ZH; Zhang HL; Liang F; Liu N; Guo SQ; Xi CX; Xi YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):123-7. PubMed ID: 16584607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular construction and characterization of a novel exotoxin fusion protein that selectively blocks the B7:CD28 costimulatory signal system.
    Xi Y; Yuan Z; Zhang H; Guan H; Kong F; Liu N; Liang F; Cui J; Guo S; Sun Y; Xi C
    J Immunother; 2006; 29(6):586-95. PubMed ID: 17063121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular design and construction of IL6D24-PE40KDEL, a novel recombinant interleukin6-pseudomonas exotoxin fusion protein, having targeted cytotoxicity for leukemias expressing interleukin6 receptors].
    Zheng LY; Xi YZ; Kong FH; Cui JW; Liang F; Liu N; Sun YY; Guo SQ
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(14):1246-50. PubMed ID: 12930640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cloning, expression and biological activity identification of a cDNA encoding the extracellular region of human b7-2].
    Yuan ZH; Xi YZ; Kong FH; Zhang HL; Nan L; Liang F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Dec; 10(6):508-11. PubMed ID: 12513710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of murine NK cells by CD40 and CD86 (B7-2).
    Martín-Fontecha A; Assarsson E; Carbone E; Kärre K; Ljunggren HG
    J Immunol; 1999 May; 162(10):5910-6. PubMed ID: 10229827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28.
    Saito K; Sakurai J; Ohata J; Kohsaka T; Hashimoto H; Okumura K; Abe R; Azuma M
    J Immunol; 1998 May; 160(9):4225-31. PubMed ID: 9574523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
    Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
    J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
    Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
    J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Langerhans' cells in vernal keratoconjunctivitis express the costimulatory molecule B7-2 (CD86), but not B7-1 (CD80).
    Abu-El-Asrar AM; Al-Kharashi SA; Al-Mansouri S; Missotten L; Geboes K
    Eye (Lond); 2001 Oct; 15(Pt 5):648-54. PubMed ID: 11702979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovium infiltrating T cells induce excessive synovial cell function through CD28/B7 pathway in patients with rheumatoid arthritis.
    Shimoyama Y; Nagafuchi H; Suzuki N; Ochi T; Sakane T
    J Rheumatol; 1999 Oct; 26(10):2094-101. PubMed ID: 10529123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7.2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA4 binding: implications for induction of antitumor immunity to T cell tumors.
    Greenfield EA; Howard E; Paradis T; Nguyen K; Benazzo F; McLean P; Höllsberg P; Davis G; Hafler DA; Sharpe AH; Freeman GJ; Kuchroo VK
    J Immunol; 1997 Mar; 158(5):2025-34. PubMed ID: 9036945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
    Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
    Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B70 antigen is a second ligand for CTLA-4 and CD28.
    Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
    Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BBL enhances anti-tumor responses in the presence or absence of CD28 but CD28 is required for protective immunity against parental tumors.
    Guinn BA; Bertram EM; DeBenedette MA; Berinstein NL; Watts TH
    Cell Immunol; 2001 May; 210(1):56-65. PubMed ID: 11485353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human B7.2 IgV-like domain expressed in bacteria maintains its co-stimulatory activity in vitro.
    Yan X; Ma J; Zheng J; Lai B; Geng Y; Wang Y; Si L
    Chin Med J (Engl); 2002 Jul; 115(7):1053-7. PubMed ID: 12150742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.